Aggressive Variant Prostate Carcinoma: Clinical Trials

1 trial for Aggressive Variant Prostate Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow Aggressive Variant Prostate Carcinoma: new trials by email Literature Review of Aggressive Variant Prostate Carcinoma trials Research Report on Aggressive Variant Prostate Carcinoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers
Ipilimumab, Valemetostat - Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma
Phase 1Active not recruitingM.D. Anderson Cancer Center652020-08-202026-11-17

Narrower conditions

Carcinoma, Renal Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Clear-cell metastatic renal cell carcinoma (1)  ·  Neoplasm Metastasis (1)  ·  Prostatic Neoplasms (1)

Broader conditions

Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Kidney Diseases (1)  ·  Kidney Neoplasms (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplastic Processes (1)

Interventions

CTLA-4 Antigen (1)  ·  Ipilimumab (1)

Sponsors

M.D. Anderson Cancer Center (1)

Countries

United States (1)

Top investigators

Ana Aparicio (1)